<DOC>
	<DOCNO>NCT00189397</DOCNO>
	<brief_summary>The dermatitis cause substance come contact skin know contact dermatitis . When reaction cause agent suspended air , call air-borne contact dermatitis ( ABCD ) . Parthenium hysterophorus present commonest cause ABCD India though case plant also find cause ABCD . Parthenium dermatitis one major health problem dermatology country . Though little mortality , disease normally continue persist variable remission relapse cause great distress morbidity . Corticosteroids , topical systemic mainstay treatment far . Therefore , patient ABCD take corticosteroid long period time tend develop severe sometimes irreversible side effect therapy . Azathioprine immunosuppressive drug act inhibit T lymphocyte . In previous study able induce remission patient azathioprine use daily well monthly bolus dose , without use systemic corticosteroid . The side effect azathioprine study almost absent . We therefore plan study therapeutic efficacy azathioprine weekly pulse dos versus daily azathioprine achieve remission patient Parthenium dermatitis monitor side effect regimens .</brief_summary>
	<brief_title>Azathioprine Versus Corticosteroids Parthenium Dermatitis</brief_title>
	<detailed_description>Detailed research plan Clinical evaluation About 60 clinically diagnosed adult patient Parthenium dermatitis take study . Pregnant female lactate mother exclude . All patient patch test standardised aqueous extract Parthenium hysterophorus confirm diagnosis show positive patch test reaction standardise extract test serial dilution antigens determine titre contact hypersensitivity ( TCH ) .20 Antibodies role disease therefore estimation immunoglobulins do . The diagnosis do patch test . It randomise , clinically study patient randomly treat azathioprine 300 mg per week azathioprine 100 mg day orally along topical clobetasol propionate 0.05 % w/w oral cetirizine hydrochloride 10 mg daily symptomatic relief . No drug include medicine alternate system give dermatitis . Clinical evaluation patient undertaken every four week . This continue six month . After 6 month treatment stop patient follow another 6 month . The graphic record disease activity treatment maintain . In addition , patient evaluate side effect regimens clinically well laboratory parameter per proforma enclose , especially haemoglobin , total blood count , differential count , platelet , serum bilirubin , serum alkaline phosphate , serum transaminase , serum electrolyte , serum creatinine , blood urea , blood sugar , urine routine microscopy stool examination occult blood . These test carry start therapy repeat every month follow period . Chest X-ray electrocardiogram TCH also do therapy six month unless otherwise require . At end study period , final evaluation base change severity dermatitis , change titre contact hypersensitivity side effect drug make . Statistical analysis use chi-square test do .</detailed_description>
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Azathioprine</mesh_term>
	<criteria>All adult patient ABCD , show clinical manifestation positive patch test Parthenium , willing participate study . Patients age 18 year Pregnant lactating woman . Patients whose baseline investigation reveal hematological abnormality abnormality liver renal function .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>May 2008</verification_date>
	<keyword>Parthenium dermatitis</keyword>
</DOC>